Ewing sarcoma: prognostic criteria, outcomes and future treatment.
about
UK guidelines for the management of bone sarcomasBone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.UK Guidelines for the Management of Bone Sarcomas.Pre-clinical and clinical significance of heparanase in Ewing's sarcoma.Differential disruption of EWS-FLI1 binding by DNA-binding agents.Gastric Ewing sarcoma/primitive neuroectodermal tumor: A case report.Imaging pediatric bone sarcomas.Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma.Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan.Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivoPreclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Stomach.Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.State-of-the-art approach for bone sarcomas.The ets transcription factor Fli-1 in development, cancer and disease.Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors.The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma.Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q26752425-22C7C5F8-92D5-4477-A0CF-481777D5FD9BQ33274572-97AC837B-1EAE-45E2-BE1F-AF4623A89F5CQ33408460-5E9E8118-9628-4C2B-9E08-B1B982630239Q34496992-3BA2C81D-11EE-4873-AEAA-E18B3441CD89Q34664539-590CDD75-0C60-40D7-82B2-7FC102C9DA3FQ34874355-5072F9DB-025A-4E6B-8CEF-72363909E0D9Q36135781-43336D71-A1BE-404D-8DAF-18F4FC73AF99Q36499007-5C0271D3-DA7F-458D-909C-2BFEA266E72EQ36756669-F7982435-0A52-49F9-979C-3C7F74B73BBEQ36988855-4E7B811A-F84E-4B91-83EE-34990EFACBC8Q37029379-46C2FC1E-76C0-4D6A-B261-38FE4D179734Q37256170-240C0CEC-E4CA-41CE-B8D1-2ED4775B5596Q37428278-27D1960B-7B2D-4447-951C-AB59EDE72E82Q37716119-3925323D-C38B-4857-9F4A-A8D6AB5313D0Q38208930-DEBA069A-C5ED-46A7-B5E3-213AF1166552Q38218534-C750CF53-743F-426C-AB42-6A3C35C1323AQ41093026-4A93CDB0-DB91-4D0A-B372-C7E61A40F4ADQ42625626-6F489022-361A-4382-B86D-E66FB88E068AQ43833260-9287A6CE-8A6A-4074-ACE1-55594A8C801AQ45969231-EFAE5D71-A5A7-4EF9-9223-6C16C17236C9Q57570627-2B3CD0DE-C452-47F1-BD89-004F4E40C55C
P2860
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@en
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@nl
type
label
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@en
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@nl
prefLabel
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@en
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@nl
P2860
P356
P1476
Ewing sarcoma: prognostic criteria, outcomes and future treatment.
@en
P2093
Anderson B Collier
Patrick J Leavey
P2860
P304
P356
10.1586/14737140.8.4.617
P577
2008-04-01T00:00:00Z